Literature DB >> 10479359

Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants.

P Li1, S E Tabibi, S H Yalkowsky.   

Abstract

This study investigates the roles of both ionized and un-ionized species of flavopiridol in solubilization by complexation, micellization, and cosolvency. Control of pH was used in combination with surfactants (polysorbate 20 and polysorbate 80), cosolvents (ethanol and propylene glycol), as well as uncharged and anionic complexing agents [hydroxypropyl beta-cyclodextrin (HPbetaCD) and sulfobutyl ether beta-cyclodextrin (SBEbetaCD)] to solubilize flavopiridol. These combined techniques increase not only the solubility of the un-ionized flavopiridol but also the solubility of the ionized drug. This study confirms that previously developed equations effectively characterize the roles of pH, pK(a), and either complexation constant, micelle partition coefficient, or cosolvent solubilizing power in determining drug total aqueous solubility.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479359     DOI: 10.1021/js990097r

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  A novel liposomal formulation of flavopiridol.

Authors:  Xiaojuan Yang; Xiaobin Zhao; Mitch A Phelps; Longzhu Piao; Darlene M Rozewski; Qing Liu; L James Lee; Guido Marcucci; Michael R Grever; John C Byrd; James T Dalton; Robert J Lee
Journal:  Int J Pharm       Date:  2008-08-20       Impact factor: 5.875

2.  A study on solubilization of poorly soluble drugs by cyclodextrins and micelles: complexation and binding characteristics of sulfamethoxazole and trimethoprim.

Authors:  Sinem Göktürk; Elif Çalışkan; R Yeşim Talman; Umran Var
Journal:  ScientificWorldJournal       Date:  2012-04-29

3.  Development of a novel approach to enhance the solubility of ftibamzone formulation.

Authors:  Ofonime Udofot; Kristen Jaruszewski; Shawn Spencer; Edward Agyare
Journal:  Integr Mol Med       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.